Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells

International Urology and Nephrology

Volumn 46, Issue 5, 2014, Pages 915-920

  Teng, Lichen ^a   Chen, Yongsheng ^a   Ding, Dexin ^a   Dai, Hongshuang ^a   Liu, Guobin ^a   Li, Changfu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Conditioned media; Dendritic cells; Renal cell carcinoma; Response

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA; CULTURE MEDIUM; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ADULT; ARTICLE; CD14+ MONOCYTE; CD25+ FOXP3+ REGULATORY T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALE; MONOCYTE; PHENOTYPE; REGULATORY T LYMPHOCYTE; SUPERNATANT; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; UPREGULATION; CELL MOTION; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KIDNEY TUMOR; METABOLISM; PHARMACOLOGY; TUMOR CELL CULTURE;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CARCINOMA, RENAL CELL; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULINS; INTERLEUKIN-10; KIDNEY NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84903740607     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0595-8     Document Type: Article

References (17)

1. Luczyńska E, Dyczek S, Heinze-Paluchowska S, Komorowski A, Pawlik T, Wysocki W, Klimek M (2013) Nephrectomy or nephron-sparing surgery: how to decide? Contemp Oncol (Pozn) 17(1):88-93
2. Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG (2012) Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol 188(6):2077-2083
3. Banchereau J, Palucka AK (2005) Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5(4):296-306 (Pubitemid 40516155)
4. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245-252 (Pubitemid 28155090)
5. Obryshev YV, Tran D, Killingsworth MC, Buckland M, Lord RV (2009) B Dendriti cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus. J Gastrointest Surg 13(3):442-450
6. Halama N, Michel S, Kloor M, Zoernig I, Pommerencke T, von Knebel Doeberitz M, Schirmacher P, Weitz J, Grabe N, Jäger D (2009) The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy. Cancer Immun 9:1
7. Kobayashi M, Suzuki K, Yashi M, Yuzawa M, Takayashiki N, Morita T (2007) Tumor infiltrating dendritic cells predict treatment response to immunotherapy in patients with metastatic renal cell carcinoma. Anticancer Res 27(2):1137-1141 (Pubitemid 46587031)
8. Hou MM, Chang JW, Pang ST, Chiang YJ, Shen YC, Liao SK, Hsieh JJ, Yeh KY, Chang NJ, Chuang CK (2010) Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinoma. Chang Gung Med J 33(1):25-35
9. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4(3):585-593 (Pubitemid 28193556)
10. Troy AJ, Davidson PJ, Atkinson CH, Hart DN (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. J Urol 161(6):1962-1967 (Pubitemid 29420779)
11. Middel P, Brauneck S, Meyer W, Radzun HJ (2010) Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma. BMC Cancer 10:578
12. Teng L, Liu L, Su Y, Yuan X, Li J, Fu Q, Chen S, Wang C (2011) Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media. J Surg Res 171(2):797-806
13. Feijoó E, Alfaro C, Mazzolini G, Serra P, Peñuelas I, Arina A, Huarte E, Tirapu I, Palencia B, Murillo O, Ruiz J, Sangro B, Richter JA, Prieto J, Melero I (2005) Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer 116(2):275-281 (Pubitemid 40967265)
14. Michielsen AJ, Hogan AE, Marry J, Tosetto M, Cox F, Hyland JM, Sheahan KD, O'Donoghue DP, Mulcahy HE, Ryan EJ, O'Sullivan JN (2011) Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer. PLoS ONE 6:e27944
15. Imai K, Minamiya Y, Koyota S, Ito M, Saito H, Sato Y, Motoyama S, Sugiyama T, Ogawa J (2012) Inhibition of dendritic cell migration by transforming growth factor-β1 increases tumordraining lymph node metastasis. J Exp Clin Cancer Res 31:3
16. Baumgartner JM, Jordan KR, Hu LJ, Wilson CC, Banerjee A, McCarter MD (2012) DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors. J Surg Res 176(1):301-308
17. Marguti I, Yamamoto GL, da Costa TB, Rizzo LV, de Moraes LV (2009) Expansion of CD4 + CD25 + Foxp3 + T cells by bone marrow-derived dendritic cells. Immunology 127(1):50-61